MENU
+Compare
HLNCF
Stock ticker: OTC
AS OF
Dec 26 closing price
Price
$5.05
Change
+$0.05 (+1.00%)
Capitalization
44.8B

HLNCF HALEON PLC Forecast, Technical & Fundamental Analysis

Haleon is one of the largest consumer health companies in the world... Show more

HLNCF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HLNCF with price predictions
Dec 26, 2025

HLNCF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for HLNCF turned positive on December 18, 2025. Looking at past instances where HLNCF's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 18, 2025. You may want to consider a long position or call options on HLNCF as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

HLNCF moved above its 50-day moving average on December 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HLNCF advanced for three days, in of 101 cases, the price rose further within the following month. The odds of a continued upward trend are .

HLNCF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 157 cases where HLNCF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLNCF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.088) is normal, around the industry mean (21.577). P/E Ratio (22.379) is within average values for comparable stocks, (74.473). Projected Growth (PEG Ratio) (2.920) is also within normal values, averaging (1.981). Dividend Yield (0.018) settles around the average of (0.030) among similar stocks. P/S Ratio (3.088) is also within normal values, averaging (64.586).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HLNCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLNCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HLNCF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
The Heights
Phone
+44 1932822000
Employees
25408
Web
https://www.haleon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO68.870.46
+0.67%
Halozyme Therapeutics
CEPT11.14N/A
N/A
Cantor Equity Partners II Inc
CCLDO25.47-0.02
-0.08%
CareCloud
WMK65.06-0.86
-1.30%
Weis Markets
LICN2.97-0.19
-6.00%
Lichen International Limited

HLNCF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+1.00%
HLN - HLNCF
49%
Loosely correlated
+0.30%
SGIOF - HLNCF
21%
Poorly correlated
N/A
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
+0.59%
TAK - HLNCF
10%
Poorly correlated
+0.45%
More

Groups containing HLNCF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+1.00%
Pharmaceuticals
category (375 stocks)
22%
Poorly correlated
-0.12%
Pharmaceuticals: Generic
category (212 stocks)
13%
Poorly correlated
+0.10%